Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Short SellingSee which listed companies have disclosed short interest
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Nightingale Health

1.17 EUR+1.75 %16/10 17:29
4,810 following

HEALTH

NASDAQ Helsinki

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Short Selling
Investor views
Compare
+1.75 %
+23.15 %
+36.74 %
-9.69 %
-43.17 %
-51.56 %
+4.39 %
-67.91 %
-77.38 %

Nightingale Health operates in the medical technology sector. The company specializes in the development of medical technology products. The product portfolio is broad and includes platforms and services within blood analysis that are used for disease prevention purposes. In addition to the main business, service and related ancillary services are also offered. The business is operated globally with the largest presence in Europe.

Read more
Market cap
70.99M EUR
Turnover
17.53K EUR
P/E (adj.) (27e)
-5.04
EV/EBIT (adj.) (27e)
-3.06
P/B (27e)
1.89
EV/S (27e)
3.59
Dividend yield-% (27e)
-
Coverage
Recommendation
Accumulate
Target price
1.30 EUR
Updated
2026-10-08
Disclaimer
Antti Luiro
Antti Siltanen
Antti Siltanen, Antti Luiro
Show more
Latest research

Latest analysis report

Released: 2026-10-08

Latest extensive report

Released: 2025-06-13

Revenue and EBIT-%
EPS and dividend
Financial calendar
Risk
Business risk
Valuation risk
Low
High
All
Research
Webcasts
Press releases
ShowingAll content types

Forum discussions
You were on the right track here @NukkeNukuttaja, the comment should have been included in the morning review, but it got overlooked during our holiday rotation updates big apologies for the delay! The comment is out now. Long story short: great to see that a clearly larger project...
10/1/2026, 11:49 AM
by Antti Luiro
20
Out of interest, I looked closer into Alamar and its business model. Quite an interesting clip on YouTube. Investor-oriented speculation… Only a fifth of Alamar’s revenue actually comes from sample analyses. If/when they land a large order, they might run it through one of their ...
10/5/2026, 10:50 AM
by Cle
18
Inderes Nightingale Healthin sairastumisriskien tunnistus osaksi työttömien... Nightingale Health Oyj | Lehdistötiedote | 05.10.2026 klo 10:10:00 EESTPohjois-Karjalan hyvinvointialue – Siun sote ottaa Nightingale Healthin (Nasdaq Helsinki: HEALTH; OTCQX: NHLTY, NGHLF) ...
10/5/2026, 7:11 AM
by Pertti
17
Antti and Antti Co. have published a new company report on Nightingale. Nightingale Health recently announced that it has signed a service agreement with The Michael J. Fox Foundation valued at approximately EUR 5.8 million. Based on the agreement, we are raising our forecasts, particularl...
10/8/2026, 5:34 AM
by Sijoittaja-alokas
14
Nightingale Health Shares Surge 32 Percent – New Order Exceeds Entire Previous Year’s Revenue A EUR 5.8 million protein analysis order from The Michael J. Fox Foundation boosted the share price by nearly 32 percent on Thursday and provides much-needed visibility for the company’s...
10/2/2026, 12:10 PM
by TO
12
Here are Siltanen’s comments on this as well, regarding the North Karelia wellbeing services county incorporating disease risk identification into health checkups for the unemployed in a pilot starting this October. We consider the news to be a positive step, as public primary healthcare...
10/6/2026, 4:43 AM
by Sijoittaja-alokas
9
Only clinical applications make Nightingale a valuable player – research helps justify it, but doesn’t in itself generate shareholder value. Both Terveystalo and the North Karelia wellbeing services county are clinical applications, but the real money is abroad. Like in the solutions...
10/9/2026, 7:31 AM
by omegaalpha
6
Read more on our forum
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
5/11
2026

General meeting '26

9/3
2027

Interim report Q2'27

Nightingale: Growth boost from proteomics
Research2026-10-08 09:01 by
Antti Siltanen, Antti Luiro

Nightingale: Growth boost from proteomics

The protein analysis project will generate significant growth for the current fiscal year.

Nightingale Health
Nightingale's tests integrated into Siun sote's health checks
Analyst Comment2026-10-06 08:11 by
Antti Siltanen

Nightingale's tests integrated into Siun sote's health checks

North Karelia is adopting risk tests as part of statutory health checks.

Nightingale Health
Press release2026-10-05 09:10

Nightingale Health's disease risk detection becomes part of health checks for the unemployed in the Wellbeing Services County of North Karelia in Finland

Nightingale Health

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release2026-10-01 16:15

Notice to the Annual General Meeting of Nightingale Health Plc

Nightingale Health
Nightingale secures a major 5.8 MEUR project with the Michael J. Fox Foundation
Analyst Comment2026-10-02 09:30 by
Antti Luiro

Nightingale secures a major 5.8 MEUR project with the Michael J. Fox Foundation

To the best of our knowledge, this is the company’s most valuable commercial contract to date and demonstrates once again the company’s ability to carry out large-scale research projects.

Nightingale Health
Regulatory press release2026-10-01 07:30

Nightingale Health’s Annual Report for financial year 2025–2026 has been published

Nightingale Health
Regulatory press release2026-09-30 19:09

Inside information: Nightingale Health signs USD 6.5 million proteomics agreement with the Michael J. Fox Foundation for neurodegenerative disease research

Nightingale Health
Press release2026-09-29 08:00

Nightingale Health's disease risk detection becomes available in Latvia through Professor Skride's Heart Clinic

Nightingale Health
Regulatory press release2026-09-28 11:56

Conversion of Nightingale Health Plc’s Series A shares to Series B shares

Nightingale Health
Agreement between Nightingale and Archipelago Health
Analyst Comment2026-09-24 07:31 by
Antti Siltanen

Agreement between Nightingale and Archipelago Health

The service agreement opens a new distribution channel to the Caribbean and the British Crown Dependencies.

Nightingale Health
Press release2026-09-23 08:52

Nightingale Health and Archipelago Health enter into agreement to bring the Nightingale Health Check to the Crown Dependencies, Bermuda and the Caribbean

Nightingale Health
Nightingale's tests to become part of Coronaria's weight management service
Analyst Comment2026-09-22 08:15 by
Antti Siltanen

Nightingale's tests to become part of Coronaria's weight management service

Numerous small contracts support our growth forecasts.

Nightingale Health
Press release2026-09-22 06:20

Nightingale Health's Remote Health Check becomes part of Coronaria's new weight management service in Finland

Nightingale Health
Nightingale H2'26: The mission is clear – deals, deals, deals!
Research2026-09-17 09:52 by
Antti Siltanen, Antti Luiro

Nightingale H2'26: The mission is clear – deals, deals, deals!

The company is investing fully in sales to achieve its growth targets.

Nightingale Health
Nightingale Health H2'26: Projects are progressing24:54
Video2026-09-16 15:57 by
Antti Siltanen

Nightingale Health H2'26: Projects are progressing

During the second half of the financial year, Nightingale Health's revenue grew to 3.09 MEUR.

Nightingale Health
Nightingale Health 2025–2026 Results Webcast
Webcast2026-09-16 13:00

Nightingale Health 2025–2026 Results Webcast

Nightingale Health
Regulatory press release2026-09-16 08:00

Nightingale Health Plc Financial Statements Release 1 July 2025 – 30 June 2026

Nightingale Health
Nightingale to start Eloisa pilot in public healthcare
Analyst Comment2026-09-15 07:19 by
Antti Siltanen

Nightingale to start Eloisa pilot in public healthcare

The Eloisa project opens the door towards public healthcare.

Nightingale Health
Press release2026-09-14 15:56

Nightingale Health's disease risk detection becomes part of public primary healthcare in South Savo: registration for Eloisa's Wellbeing Gift opened today

Nightingale Health
Nightingale H2'26 preview: Growth driven by research projects and Terveystalo
Analyst Comment2026-09-11 08:05 by
Antti Siltanen

Nightingale H2'26 preview: Growth driven by research projects and Terveystalo

We estimate that H2 revenue grew by 47%, driven by research projects and the Terveystalo partnership.

Nightingale Health